Literature DB >> 20021319

Progressive structural brain changes in schizophrenia.

Basant K Puri1.   

Abstract

Several important progressive brain changes occur in schizophrenia. Continuous progressive brain tissue decreases and lateral ventricular volume increases in chronically ill patients, up to at least 20 years after their first symptoms. The total duration of psychosis may be negatively associated with the grey matter volume change, and positively associated with the volume change of each of the lateral ventricles and the third ventricle. There are progressive frontal changes in males with adolescent-onset psychosis. Ultra high-risk patients who subsequently develop psychosis and first-episode psychosis patients develop significant grey matter reduction in the planum polare, planum temporale and caudal region; a progressive process in the superior temporal gyrus may precede the first expression of florid psychosis. The rate of decline in the sizes of the putamen and corpus callosum is greater in patients with a poor outcome compared to those with a good-outcome. In addition to describing these phenomena, their potential causes are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20021319     DOI: 10.1586/ern.09.142

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  11 in total

1.  Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia.

Authors:  Rubén Antonio Vázquez-Roque; Brenda Ramos; Carolina Tecuatl; Ismael Juárez; Anthony Adame; Fidel de la Cruz; Sergio Zamudio; Raúl Mena; Edward Rockenstein; Eliezer Masliah; Gonzalo Flores
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

Review 2.  Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?

Authors:  Nenad Vasic; Bernhard J Connemann; Robert C Wolf; Hayrettin Tumani; Johannes Brettschneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-16       Impact factor: 5.270

Review 3.  Staging perspectives in neurodevelopmental aspects of neuropsychiatry: agents, phases and ages at expression.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 4.  The development of psychotic disorders in adolescence: a potential role for hormones.

Authors:  Hanan D Trotman; Carrie W Holtzman; Arthur T Ryan; Daniel I Shapiro; Allison N MacDonald; Sandra M Goulding; Joy L Brasfield; Elaine F Walker
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

Review 5.  Stress and neurodevelopmental processes in the emergence of psychosis.

Authors:  C W Holtzman; H D Trotman; S M Goulding; A T Ryan; A N Macdonald; D I Shapiro; J L Brasfield; E F Walker
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

Review 6.  Developmental mechanisms in the prodrome to psychosis.

Authors:  Elaine F Walker; Hanan D Trotman; Sandra M Goulding; Carrie W Holtzman; Arthur T Ryan; Allison McDonald; Daniel I Shapiro; Joy L Brasfield
Journal:  Dev Psychopathol       Date:  2013-11

7.  Cortical grey matter and subcortical white matter brain microstructural changes in schizophrenia are localised and age independent: a case-control diffusion tensor imaging study.

Authors:  Chiara Chiapponi; Fabrizio Piras; Federica Piras; Sabrina Fagioli; Carlo Caltagirone; Gianfranco Spalletta
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

8.  The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.

Authors:  Else-Marie Løberg; Siri Helle; Merethe Nygård; Jan Øystein Berle; Rune A Kroken; Erik Johnsen
Journal:  Front Psychiatry       Date:  2014-11-18       Impact factor: 4.157

9.  Brain network informed subject community detection in early-onset schizophrenia.

Authors:  Zhi Yang; Yong Xu; Ting Xu; Colin W Hoy; Daniel A Handwerker; Gang Chen; Georg Northoff; Xi-Nian Zuo; Peter A Bandettini
Journal:  Sci Rep       Date:  2014-07-03       Impact factor: 4.379

Review 10.  A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation.

Authors:  Rune A Kroken; Else-Marie Løberg; Tore Drønen; Renate Grüner; Kenneth Hugdahl; Kristiina Kompus; Silje Skrede; Erik Johnsen
Journal:  Front Psychiatry       Date:  2014-02-04       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.